Q91.1 Trisomy 18, mosaicism (mitotic nondisjunction)

Name of the Condition

• Trisomy 18, mosaicism (mitotic nondisjunction)

Summary

Trisomy 18, mosaicism (mitotic nondisjunction) is a chromosomal condition where some cells in the body have an extra copy of chromosome 18, while others have the typical two copies. This occurs due to errors in cell division after fertilization. The presence of both normal and abnormal cells can lead to a range of physical and developmental differences, which may be less severe than in full trisomy 18, depending on the proportion and distribution of affected cells.

Causes

This condition results from mitotic nondisjunction, an error in cell division that happens after fertilization. During early embryonic development, a cell fails to separate chromosome 18 properly, creating a cell line with three copies (trisomy) alongside normal cells with two copies. The specific triggers for this error are not always identifiable, but it is not inherited from parents in most cases.

Risk Factors

• Advanced maternal age, as the risk of chromosomal errors increases with age.
• No known modifiable risk factors, as the error occurs randomly during cell division.

Symptoms

• Variable physical features, which may include heart defects, growth delays, and distinct facial characteristics.
• Developmental delays, with severity depending on the proportion of affected cells.
• Possible organ abnormalities, such as kidney or gastrointestinal issues.

Diagnosis

Prenatal diagnosis may involve chorionic villus sampling (CVS) or amniocentesis to detect mosaicism. Postnatal confirmation typically requires karyotype analysis of blood or tissue samples to identify the presence of both normal and trisomic cell lines. The proportion of abnormal cells can influence the clinical presentation.

Treatment Options

Management is supportive and tailored to the individual’s specific symptoms. This may include surgical interventions for structural defects, physical or occupational therapy for developmental support, and monitoring for associated health issues. No cure exists, as the condition is genetic.

Prognosis and Follow-Up

Prognosis varies widely based on the extent of mosaicism and associated complications. Some individuals may have a longer lifespan with appropriate care, while others may face significant health challenges. Regular follow-up with a multidisciplinary team is essential to address evolving needs, including developmental, cardiac, and nutritional support.

Complications

• Increased risk of congenital heart defects.
• Respiratory or feeding difficulties.
• Higher susceptibility to infections due to weakened immunity.
• Potential for severe developmental delays.

Lifestyle & Prevention

No specific preventive measures exist, as the condition arises from random cellular errors. Prenatal genetic counseling may help families understand the implications and prepare for potential outcomes.

When to Seek Professional Help

Consult a healthcare provider if prenatal screening suggests chromosomal abnormalities or if postnatal symptoms (e.g., poor feeding, unusual physical features) raise concern. Early evaluation by a geneticist or pediatric specialist is recommended for accurate diagnosis and care planning.

Tips for Medical Coders

Document the presence of mosaicism and any associated clinical findings to support coding. Ensure the record specifies "mitotic nondisjunction" if applicable, as this distinguishes the condition from full trisomy 18. Include details on diagnostic testing (e.g., karyotype results) to confirm the mosaic pattern.